Cardiovascular companies develop diagnostics, therapies and research technologies for diseases affecting the heart and circulatory system. Their work supports earlier detection, improved disease management and the development of new treatments for cardiovascular conditions.
This category includes companies working on:
Browse 71 UK cardiovascular companies below.
Lateral flow and molecular diagnostic tests for multiple applications
AccuBio is a UK-based manufacturer of in-vitro diagnostic products, producing lateral flow assays and molecular diagnostic tests across infectious disease, toxicology, oncology, cardiovascular, and veterinary applications. Operating from manufacturing facilities in Alva, Scotland, acquired from Omega Diagnostics, the…
AI-assisted imaging software for minimally invasive vascular surgery
Cydar Medical is a medical software company developing AI-assisted imaging tools for minimally invasive vascular surgery. Its cloud-based platform creates three-dimensional anatomical maps from CT scans and overlays them on live X-ray images to support procedural planning and intraoperative navigation. The software…
AAV gene therapies for rare and neurological diseases
Spur Therapeutics is a clinical-stage biotechnology company developing adeno-associated virus-based gene therapies for serious chronic diseases. Its lead programme is a Phase I/II gene therapy for Gaucher disease type 1, a rare lysosomal storage disorder. Further pipeline candidates target GBA1 Parkinson's disease and…
Rapid blood biomarker test for pre-hospital stroke triage
Upfront Diagnostics is a diagnostic biotechnology company developing rapid blood tests for emergency stroke triage. Its lateral-flow assay measures D-dimer and glial fibrillary acidic protein (GFAP) from a finger-prick sample, providing results in under ten minutes to support identification of suspected…
ACE inhibitors for safer cardiovascular and fibrosis treatment
Angiodesign is a seed-stage drug discovery company developing next-generation domain-selective inhibitors of angiotensin-converting enzyme (ACE). Unlike current-generation ACE inhibitors, which cause bradykinin accumulation and limiting side effects, Angiodesign's C-domain selective inhibitors aim to reduce blood…
MicroRNA therapeutics for tendon and musculoskeletal disease
Causeway Therapeutics is a clinical-stage biotechnology company developing first-in-class microRNA therapies for musculoskeletal and age-related conditions. Its lead asset TenoMiR (CWT-001) is a synthetic miR-29a mimic delivered by single intratendinous injection that promotes collagen remodelling and tendon repair.…
Global diabetes and cardiometabolic medicines leader
Novo Nordisk Limited is the UK commercial and medical affiliate of Novo Nordisk A/S, the Danish pharmaceutical company focused on diabetes, obesity, and cardiometabolic disease. The UK operation covers commercialisation, medical affairs, and clinical trial activities. Separately, Novo Nordisk Research Centre Oxford…
AAV gene therapy platform and clinical pipeline for genetic disease
AskBio UK Ltd is the European headquarters of AskBio Inc., a fully integrated AAV gene therapy company and Bayer AG subsidiary. Operating from Roslin Innovation Centre, the Edinburgh site develops the company's synthetic promoter technology, data-driven gene expression control sequences that complement AskBio's Pro10…
Clinical whole genome sequencing and reporting platform
StoreGene is a UCL spin-out providing a clinical genomic operating system that integrates whole genome sequencing with automated bioinformatics pipelines and genomic counselling services. Its platform generates clinical reports across cardiovascular genetics, hereditary cancer, pharmacogenomics, and nutrigenetics,…
AI-powered medical imaging software for stroke, oncology and lung disease
Brainomix is a UK software company specialising in AI-powered imaging biomarkers and Software as a Medical Device (SaMD) to support clinical decision-making in stroke, lung fibrosis, and cancer. Its platform provides clinicians with automated imaging analysis to guide treatment decisions in acute stroke care and is…
UK affiliate of global innovative medicines company Novartis AG
Novartis Pharmaceuticals UK Limited is the UK commercial and medical affiliate of Novartis AG, the Swiss-headquartered global pharmaceutical company. Headquartered at White City Place in London, the UK operation employs approximately 1,300 people and focuses on commercialisation, medical affairs, regulatory…
Pre-clinical platelet function testing for drug discovery and safety
Platelet Services is a contract research organisation specialising in pre-clinical platelet function testing for pharmaceutical and biotechnology clients. The company provides standard and customised assays to assess the effects of candidate compounds on platelet activity, supporting both anti-platelet drug programmes…
In vivo safety pharmacology and cardiovascular preclinical testing
Vivonics Preclinical is a contract research organisation providing in vivo safety pharmacology studies for biotechnology and pharmaceutical drug development teams. Its services assess how experimental compounds affect vital organ function, particularly cardiovascular physiology, using telemetry, electrocardiography,…
Nonclinical safety toxicology and ion channel screening services
ApconiX is a nonclinical safety consultancy and ion channel laboratory supporting drug discovery and development programmes. The company provides project toxicology, DMPK support, target safety assessments, study outsourcing and monitoring, and specialist subject matter expertise across disciplines including safety…
Global biopharma with UK R&D centre on the Wirral Peninsula
Bristol-Myers Squibb (BMS) is a global biopharmaceutical company with a long-established UK R&D site at Moreton on the Wirral Peninsula and its UK and Ireland commercial headquarters in Uxbridge. The Moreton facility, expanded in 2025, conducts chemistry, manufacturing and control activities supporting pharmaceutical…
Genomic risk prediction platform for preventive healthcare and drug discovery
Genomics is a data science company that uses large-scale human genetic data to power precision healthcare and drug discovery. Its proprietary platform links millions of genetic variants to thousands of biological measurements and disease outcomes, generating polygenic risk scores that enable earlier identification of…
AI echocardiography platform for heart failure detection
Ultromics is an Oxford University spin-out developing AI-powered software that analyses routine echocardiogram images to detect complex cardiac conditions. Its cloud-based platform holds multiple FDA clearances and CE marks for heart failure with preserved ejection fraction and cardiac amyloidosis screening. The…
AI-driven delivery platform for siRNA therapies beyond the liver
Undecimal Bio is a biotechnology company developing targeted delivery technologies for small interfering RNA (siRNA) therapeutics beyond the liver. Its DELiveri platform combines large-scale combinatorial chemistry, functional cell-based screening and AI to identify synthetic conjugates that transport siRNA into…
AI-driven microRNA biomarker diagnostics for early veterinary disease detection
MI:RNA Diagnostics is a UK-based developer of a diagnostic platform combining microRNA biomarker panels with a proprietary artificial intelligence model to detect early-stage disease in animals. The company's flagship application targets cardiac disease in cats and dogs, with further research into Johne's disease…
siRNA therapeutics targeting liver-expressed disease genes
Silence Therapeutics is a clinical-stage biotechnology company developing siRNA therapeutics using its proprietary platform. The platform enables precise silencing of disease-associated genes expressed in the liver, without permanently altering DNA. Its pipeline addresses cardiovascular disease, haematological…